Background-Progressive familial heart block type I (PFHBI) is a hereditary arrhythmia characterized by progressive conduction disturbances in the His-Purkinje system. PFHBI has been linked to genes such as SCN5A that influence cardiac excitability but not to genes that influence cell-to-cell communication. Our goal was to explore whether nucleotide substitutions in genes coding for connexin proteins would associate with clinical cases of PFHBI and if so, to establish a genotype-cell phenotype correlation for that mutation. Methods and Results-We screened 156 probands with PFHBI. In addition to 12 sodium channel mutations, we found a germ line GJA5 (connexin40 [Cx40]) mutation (Q58L) in 1 family. Heterologous expression of Cx40-Q58L in connexin-deficient neuroblastoma cells resulted in marked reduction of junctional conductance (Cx40-wild type [WT], 22.2Ϯ1.7 nS, nϭ14; Cx40-Q58L, 0.56Ϯ0.34 nS, nϭ14; PϽ0.001) and diffuse localization of immunoreactive proteins in the vicinity of the plasma membrane without formation of gap junctions. Heteromeric cotransfection of Cx40-WT and Cx40-Q58L resulted in homogenous distribution of proteins in the plasma membrane rather than in membrane plaques in Ϸ50% of cells; well-defined gap junctions were observed in other cells. Junctional conductance values correlated with the distribution of gap junction plaques.
association between germ line mutations in gap junction proteins and inherited ventricular arrhythmias in humans.
In this study, we investigated a group of patients with progressive familial heart block type I (PFHBI) (Online Mendelian Inheritance in Man 113900), also known as progressive cardiac conduction defect or Lenègre-Lev disease, 6, 7 is a dominant inherited disorder of the His-Purkinje system. Affected individuals show electrocardiographic evidence of bundle branch disease (ie, right bundle branch block, left anterior or posterior hemiblock, complete heart block) with broad QRS complexes. The disease can progress from a normal ECG to right bundle branch block and from the latter to complete heart block. Affected individuals often present with family history of syncope, pacemaker implantation, and sudden death. 8 Although structural abnormalities have been invoked as a cause of the disease, 6,7 a number of patients present with normal cardiac structure and contractile function. Linkage analysis in a large South African PFHBI kindred 9 and a Lebanese kindred 10 mapped a causal locus on chromosome 19q13.3, and further work identified mutations in genes encoding for the transient receptor potential nonselective cation channel, subfamily M, member 4 (TRPM4) gene 11 at this locus. Haploinsufficiency of SCN5A and aging have been implicated in PFHBI, 8 and age-dependent manifestations of the disease have been recapitulated in mice. 12 Here, we sought to expand on the association between PFHBI and mutations in genes relevant to action potential propagation; in particular, we assessed the possible association between nucleotide substitutions in connexin-coding genes and PFHBI. We evaluated 156 probands of diverse ethnic backgrounds from Asia, Europe, and North America given a clinical diagnosis of PFHBI. In addition to the sodium channel mutations previously reported, [13] [14] [15] we identified a germ line missense mutation in GJA5 in a family with severe, early onset disease. This gene codes for the gap junction protein connexin40 (Cx40), which predominantly expresses in the atria and His-Purkinje system. 16 Heterologous expression experiments revealed that this novel mutation (Cx40-Q58L) significantly impaired the ability of Cx40 to form gap junction channels. Confocal microscopy showed that the Cx40-Q58L mutant but not the wild type (WT) failed to form plaques at sites of cell-cell apposition. Coexpression experiments indicated that the Cx40-WT protein provided only partial rescue of the Cx40-Q58L cellular phenotype. To our knowledge, this is the first description of a germ line mutation in a connexin gene associated with inherited ventricular arrhythmias. The results open the possibility of GJA5 as a candidate gene for screening in patients with PFHB1, yet in the absence of further evidence, screening may be limited to the research environment rather than included as a part of the routine diagnostic examination. 17 The data also emphasize the importance of Cx40 in the maintenance of normal propagation in the specialized conduction system of the human heart.
Methods

Genetic Screening of PFHB1
Genomic screening by polymerase chain reaction and DNA sequencing was performed for GJA5 (Cx40), GJA1 (Cx43), GJC1 (Cx45), KCNQ1, KCNH2, SCN5A, KCNE1, KCNE2, KCNJ2, SCN1B, SCN4B, HCN4. Primer information is provided in the online-only Data Supplement. All participating probands and family members gave written informed consent in accordance with standards (Declaration of Helsinki) and local ethics committees.
Plasmid Construction
A 1.1-kb Cx40-DNA fragment was subcloned into bicystronic plasmids pIRES2-EGFP and pIRES2-DsRED2. An EGFP or FLAG epitope was added at Cx40 C terminal to generate EGFP-or FLAG-tagged Cx40. Site-directed mutagenesis (Q58L) was performed with QuikChange. Primer information and additional details are provided in the online-only Data Supplement.
Cell Culture and Transfection
Constructs were introduced into connexin-deficient HeLa cells or mouse neuroblastoma (N2A) cells using Lipofectamine as per manufacturer's protocol.
Electrophysiology
Gap junction currents were recorded from transiently transfected N2A cell pairs using whole-cell double-patch clamp techniques as previously described. 18, 19 Further details are provided in the onlineonly Data Supplement.
Immunocytochemistry and Western Blotting
HeLa cells, transfected with pEGFPN1-Cx40-WT, pCMV-FLAG-Cx40-Q58L, or both, were stained with anti-FLAG M2 antibody and Alexa546-labeled secondary antibody. EGFP and Alexa546 fluorescence images were recorded by confocal microscopy. For western blotting, N2A cells were transiently transfected with 3 g of Cx40 plasmids. Two days after transfection, cells were lysed, and proteins were extracted and separated by conventional methods. Further details are provided in the online-only Data Supplement.
Statistical Analysis
Results are presented as meanϮSEM. Mann-Whitney rank sum tests with Bonferroni post hoc correction were used in comparisons for which normality or equal variance assumptions were invalid. In other instances, differences between groups were assessed by 1-way ANOVA followed by Bonferroni post hoc correction. Statistical significance was assumed for PϽ0.05.
Results
Genetic Screening of PFHBI Probands
We genetically screened 156 probands given a clinical diagnosis of PFHBI. We identified 4 novel and 5 previously reported mutations in SCN5A, 13, 15 3 mutations in SCN1B, 14 and a novel germ line heterozygous missense mutation in exon 2 of the Cx40 gene GJA5 (online-only Data Supplement Table I ). Mutations were not found in connexin genes GJA1 (Cx43) or GJC1 (Cx45) or in the other genes screened (KCNQ1, KCNH2, KCNE1, KCNE2, KCNJ2, HCN4, or SCN4B). Of the novel SCN5A mutations, 1 caused a modification of the amplitude and voltage gating kinetics of the sodium current in heterologously expressing cells (onlineonly Data Supplement Figure I ); 3 other mutant constructs failed to express functional channels, suggesting that patients carrying the mutation were functionally haploinsufficient for Nav1 Figure 1C ). The presence of glutamine in this position is highly conserved among GJA5 orthologs, and 2 other cardiac connexins, Cx43 and Cx45 ( Figure 1D ). The clinical and genotypic characteristics of proband and tested family members are described next.
Clinical Phenotypes and Genotype of the PFHBI Pedigree With the GJA5 Mutation
The proband, an 11-year-old boy at time of death, was first referred for evaluation when he was age 6 years because of ECG abnormalities. Although asymptomatic at that time, his ECG showed advanced atrioventricular block, complete left bundle branch block, and left axis deviation (Figure 2A ). Echocardiography and cardiac scintigraphy did not reveal signs of structural heart disease. He experienced an episode of syncope at age 9; implantation of a permanent pacemaker was recommended by the physician but not authorized by the legal guardian. The proband died suddenly 2 years later during exercise (running), and the family declined postmortem examination. The proband's younger sister shares the Cx40-Q58L mutation. She is asymptomatic, with a QRS duration at the upper limit of normal, left axis deviation that has been progressive (online-only Data Supplement Table II) , and QRS notch. These findings are consistent with impaired intraventricular conduction ( Figure 2B ). The mother died suddenly at age 30 after delivering the second child. An ECG on record, obtained when she was age 16, was similar to that of the proband (compare Figure 2C with 2A). In addition, a ventricular tachycardia was recorded during the recovery phase of an exercise stress test (online-only Data Supplement Figure II ). DNA from the mother was not available for examination. Other family members, including the proband's father, showed normal ECGs. DNA analysis of proband's father and maternal grandparents revealed absence of the Cx40-Q58L mutation. On the basis of clinical data and genotypic features of the proband and sister, it is most likely that the Cx40-Q58L mutation appeared de novo in the proband's mother. The data also indicate an early onset of PFHBI in this family compared with the natural history of the disease in most other cases. 8 As an initial step to assess the functional implications of the Cx40-Q58L mutation, modified constructs were transiently expressed in an exogenous system and evaluated for localization and function.
Electrophysiological Properties of Mutant Cx40-Q58L Channels
Connexin-deficient N2A cells were transiently transfected with cDNA for Cx40-WT or Cx40-Q58L; electrophysiolog-ical properties of homologous Cx40 channels were analyzed by conventional dual whole-cell patch clamp. Figure 3A shows representative junctional current traces elicited by a transjunctional voltage gradient of Ϫ60 mV. Average junctional conductance (Gj) decreased from 22.2Ϯ1.7 nS in cells expressing Cx40-WT (nϭ14) to 0.56Ϯ0.34 nS in cells expressing the Cx40-Q58L mutant (nϭ14; PϽ0.001). The probability of functional coupling, calculated by dividing the number of electrically coupled pairs by the number of pairs tested, was 100% and 57.1% for Cx40-WT and Cx40-Q58L, respectively. Figure 3B depicts representative single-channel recordings elicited by a transjunctional voltage of Ϫ60 mV in cell pairs expressing Cx40-WT or Cx40-Q58L. Unitary events for WT channels displayed current transitions corresponding to 2 conducting states (O 1 and O 2 ) of 43.3 and 119.5 pS, respectively. Figure 3C shows the event histograms for both cell Figure 3D ). Of note, the Q58L mutation had a strong dominant effect on formation of heterotypic functional gap junctions. Cells were transfected with either pIRES2-EGFP-Cx40-WT or pIRES2-DsRED2-Cx40-Q58L, and heterotypic pairs were identified by fluorescence microscopy (an EGFPexpressing cell paired with a DsRED2-expressing cell). We recorded from 8 cell pairs and detected unitary current events in only 2 pairs. A total of 57 events were recorded, and average macroscopic junctional conductance was 0.04Ϯ0.03 nS. Collectively, the data demonstrated that the Q58L mutation significantly affects the biophysical properties of Cx40 channels and the overall ability of Cx40 gap junctions to form a low-resistance pathway between cells.
Electrophysiological Properties and Gap Junction Plaque Formation in Cells Coexpressing WT and Q58L Proteins
In the clinical cases identified, the Q58L mutation was detected in only 1 carrier allele. Therefore, we assessed the function of gap junctions in cells coexpressing WT and mutant proteins. N2A cells were cotransfected with cDNA for both GFP-tagged Cx40-WT and Cx40-Q58L (0.5 g of pEGFPN1-Cx40-WT combined with 0.5 g of pEGFPN1-Cx40-Q58L). Results were compared with those obtained when only 1 of the constructs (1 g) was transfected. Cells expressing both constructs (WT/Q58L) showed intermediate conductance (15.4Ϯ3.7 nS, nϭ16) between WT (28.8Ϯ3.6 nS, nϭ16, PϽ0.001) and Q58L (0.28Ϯ0.11 nS, nϭ14, PϽ0.001) ( Figure 4A) . These values were comparable to those obtained using the bicistronic pIRES2-EGFP constructs (WT, 22.2Ϯ1.7 nS, nϭ14; WT/Q58L, 13.0Ϯ2.4 nS, nϭ17; Q58L, 0.56Ϯ0.34 nS, nϭ14). The coexpression results were consistent with those obtained using pIRES plasmids that tagged the cells both green and red, if cotransfected (onlineonly Data Supplement Figure I) . The probability of finding functional coupling in cotransfected cells was 76.5%, which was intermediately between WT (100%) and Q58L (57.1%).
The characteristics of gap junction plaques observed in cells coexpressing WT and Q58L varied significantly between pairs ( Figure 4B ). Nearly one half of transfected (fluorescence-positive) cells exhibited clear and discrete gap junction plaques (arrow a), whereas the rest of fluorescentpositive cells showed a diffuse expression pattern and absence of well-defined plaques (arrow b). Fluorescencepositive and gap junction plaque-positive cells were counted in 10 different views for each group, and efficacy of gap junction plaque formation was statistically analyzed ( Figure  4C ) by calculating the ratio of cells with gap junction plaques to the number of fluorescence-positive cells. In the Cx40-WT group, almost all fluorescent-positive cells exhibited clear gap junction plaques (94.9Ϯ1.9%, nϭ940), whereas there was a more-diffuse and homogenous pattern with only occasional plaque formation in the Cx40-Q58L group (6.6Ϯ0.7%, nϭ1318, PϽ0.001 compared with WT). In contrast, results varied widely in cells cotransfected with WT/Q58L; nearly one half of fluorescence-positive cells exhibited gap junction plaques similar to those observed in cells transfected with the WT construct (48.2Ϯ2.4%, nϭ855, PϽ0.001), whereas the rest showed a diffuse expression pattern similar to that of Cx40-Q58L. To establish a better correlation between plaque formation and junctional conductance, both variables were measured concurrently in the same cell pair for 39 N2A cell pairs where GFP-tagged plasmids of Cx40-WT and Cx40-Q58L were cotransfected. As shown in Figure 4D , about one half of GFP-positive cell pairs showed a very small Gj (Ͻ5 nS) and very few or negligible gap junction plaques (a). In the other half of cell pairs, small, dot-like junctional plaques correlated with intermediate Gj values (b), and there were clear, extensive gap junction plaques associated with Gj values Ͼ25 nS (c). Overall, we found significant heterogeneity in the extent of electric coupling, although the measurements of Gj correlated with the localization of proteins in transfected cells. These results indicate that the Q58L mutation significantly impairs the ability of cells to form gap junction plaques, although the effect is not purely dominant when both WT and mutant proteins are coexpressed.
Subcellular Distribution of WT and Q58L Cx40 in Transiently Transfected Cells
To further analyze the subcellular distribution of Cx40-WT and Cx40-Q58L proteins, the C terminal of Cx40-WT was . Macroscopic conductance and gap junction plaque morphology in cells coexpressing connexin40 (Cx40)-WT and Cx40-Q58L. A, Junctional conductance of cells transfected with plasmid pEGFPN1-Cx40-WT (1 g), pEGFPN1-Cx40-Q58L (1 g), or cotransfected with WT and Q58L (WT/Q58L, pEGFPN1-Cx40-WT 0.5gϩpEGFPN1-Cx40-Q58L 0.5 g). B, Phase contrast/fluorescence overlay image of neuroblastoma cells transfected with WT/Q58L constructs. Arrow a points to gap junction plaque; arrow b points to an example of cells transfected but devoid of gap junction plaque. C, Efficacy of gap junction plaque formation was measured as the ratio between the number of gap junction plaque-positive cells and the number of fluorescent-positive cells (WT, nϭ940; WT/Q58L, nϭ855; Q58L, nϭ1318). D, Representative images of phase contrast (left), EGFP fluorescence (middle), and junctional conductance (right) from neuroblastoma cells cotransfected with pEGFPN1-Cx40-WT (0.25 g) and pEGFPN1-Cx40-Q58L (0.25 g). Three different examples illustrate the relation between plaque morphology and recorded junctional conductance. WT indicates wild type. ***PϽ0.001 compared with WT.
tagged with GFP, whereas the C terminal of Cx40-Q58L was FLAG tagged. After transfection of N2A cells with the tagged constructs, the distribution of each protein was examined by confocal microscopy. As shown in Figure 5 , green color indicates the position of GFP-tagged molecules, whereas red indicates the position of FLAG-tagged molecules. In cells transfected only with GFP-tagged Cx40-WT, fluorescence was consistently detected at sites of cell-cell apposition, following the pattern previously described for GFP-labeled gap junction plaques ( Figure 5A) . A similar distribution was found when cells were transfected with FLAG-tagged Cx40-WT (not shown). In contrast, most FLAG-tagged Cx40-Q58L signals were evenly distributed around the cell in the vicinity of the plasma membrane ( Figure 5B ). Biotinylation experiments showed that the Q58L mutation did not prevent the Cx40 protein from inserting into the membrane and presenting a domain-reachable form in the extracellular space (online-only Data Supplement Figure II) . Micoscopy experiments in cells coexpressing GFP-tagged Cx40-WT and FLAG-tagged Cx40-Q58L proteins yielded results intermediate to those obtained when only 1 construct was expressed. Nearly one half of cell pairs showed that both proteins distributed homogenously at or near the cell membrane, without the formation of well-defined gap junction plaques ( Figure 5C ). These images resembled those obtained when only Cx40-Q58L proteins were expressed ( Figure 5B,  FLAG) . In contrast, other cell pairs showed clustering of fluorescent signals within closely confined areas that appeared to be gap junction plaques ( Figure 5D) .
The experiments described herein led us to speculate that the distribution and function of heteromeric connexons is determined by their mutant subunit content, whereby formation (or not) of plaques and channels are determined, at least in part, by the abundance of expression of one protein over the other. As an initial step to probe this hypothesis, we took advantage of the characteristics of the bicistronic plasmid pIRES, in which the expression rate of the upstream gene is several-fold greater than that of the downstream gene, 20 and explored the functional properties of heteromeric connexons. Cx40-WT and GFP-tagged Cx40-Q58L were subcloned into the pIRES vector, either alone or in combination, in the specific orientations shown in Figure 6A . Protein expression levels of Cx40-WT and Cx40-Q58L were determined by immunochemistry. In contrast to the data obtained when Cx40-WT and GFP-tagged Cx40-Q58L plasmids were cotransfected at a 1:1 ratio (lane 6), expression of heteromeric pIRES plasmids WT-IRES-Q58L-EGFP (lane 3) and Q58L-EGFP-IRES-WT (lane 4) resulted in uneven protein expression levels of WT (40 kDa) and Q58L-EGFP (67 kDa), depending on their orientation in the pIRES vector. Based on these observations, we constructed a homomeric Cx40-WT plasmid (WT-IRES-WT) and heteromeric plasmids of Cx40-WT and Cx40-Q58L with different orientations (WT-IRES-Q58L and Q58L-IRES-WT) ( Figure 6B ). The junctional conductance of cell pairs expressing WT-IRES-Q58L (25.3Ϯ2.8 nS, nϭ17) was nearly indistinguishable from that of the homomeric plasmid WT-IRES-WT (27.8Ϯ1.4 nS, nϭ17, P not significant). By contrast, the converse heteromeric construct Q58L-IRES-WT showed substantially reduced junctional conductance (0.29Ϯ0.12 nS, nϭ15, PϽ0.001) comparable with that of the homomeric Q58L (0.56Ϯ0.34 nS) ( Figure 3A) . These results suggest that the final electrophysiological properties of the heteromeric connexons are determined predominantly by the numbers of mutant subunits in each gap junction rather than defined by a dominant-negative effect.
Discussion
Genetic screening confirmed the association of SCN5A and SCN1B with PFHB1 [13] [14] [15] and revealed novel mutations within these genes (online-only Data Supplement Table I ). More importantly, we identified a particularly severe, early onset case of PFHBI associated with a germ line mutation in GJA5 in 2 blood relatives (proband and sister) given a clinical diagnosis of PFHBI. The data also indicate that the protein expressed (Cx40-Q58L) failed to form functional gap junc-tions in an exogenous expression system and decreased the probability of gap junction formation in cells coexpressing the WT protein.
So far, SCN5A, SCB1B, and TRPM4 are the only genes associated with PFHB1. 11, 13, 14 The National Human Genome Research Institute database shows no association of GJA5 single-nucleotide polymorphisms with arrhythmias or conduction system diseases. PR interval and QRS have been associated with several loci, including SCN5A, SCN10A, NKX2.5, and TBX5 21, 22 but not GJA5, which is located at chromosome 1q21.1. Overall, the present results suggest that GJA5 is a candidate gene associated with PFHBI, likely in a small fraction of the affected population. Yet, given the limited cosegregation observed in the reported family, we remain cautious in assigning a causative nature to the GJA5 mutation. It will be of great interest to expand the screening of GJA5 at the research level to identify other cases associated with amino acid changes in Cx40, although it may be premature to include GJA5 as a part of the routine diagnostic screen. 17 The present results also emphasize the importance of Cx40 in the maintenance of normal cardiac rhythm.
To our knowledge, this is the first report of a germ line mutation in Cx40 associated with a high risk of ventricular arrhythmias (online-only Data Supplement Figure II) . Other studies have shown somatic mutations of Cx40 or Cx43 in patients with idiopathic atrial fibrillation 5, 23 ; those mutations Conductance of cell pairs expressing WT-IRES-WT (nϭ17) was comparable to heteromeric construct WT-IRES-Q58L (nϭ17). However, converse heteromeric construct Q58L-IRES-WT (nϭ15) showed significantly reduced conductance (PϽ0.001 versus WT-IRES-WT and WT-IRES-Q58L). ***PϽ0.001. NS indicates not significant; WT, wild type.
were confined to the atria, and conduction abnormalities in the ventricles or His-Purkinje system were not observed. On the other hand, as in all cases involving identified genetic substrates for disease, the possibility of compound mutations in unexamined genes cannot be excluded. We do emphasize that the mutation led to a severe cellular phenotype in an exogenous expression system, supporting the argument that just the Q58L substitution can impair the formation of gap junctions necessary for propagation of action potentials between cells.
The results show that Cx40-Q58L was abundantly expressed in an exogenous system. The protein reached the vicinity of the cell membrane but failed to form gap junction plaques ( Figure 5B ). This result may be due to impaired docking of mutant hemichannels within the intercellular space because of the mutation in the extracellular loop ( Figure 1C ). During trafficking, connexin subunits oligomerize to form a hemichannel (or connexon). Once at the site of cell contact, connexons from apposing cells dock, sealing the hydrophilic path (the channel pore) from the extracellular space. The locking of 2 connexons into 1 gap junction channel is believed to stabilize connexin subunits in place, facilitating aggregation of other oligomers into their vicinity and eventually forming a plaque. Amino acid substitutions within the extracellular loop, as in Q58L, can prevent hemichannel docking and, thus, plaque formation. 24 The present biotinylation experiments indicate that the Q58L protein integrates into the cell membrane, supporting the notion that the inability of the Q58L mutation to form functional gap junctions is related to events that occur after the oligomer is delivered to the cell membrane and before a functional dodecamer converts into a functional channel in a gap junction plaque.
Results obtained in cells coexpressing both mutant and WT proteins clearly show that one subunit can significantly influence the fate of the other ( Figure 5 ). This suggests that Cx40-Q58L subunits retain their ability to oligomerize not only with other mutant subunits, but also with the WT protein. The results also present an interesting paradigm in that neither the WT nor the mutant construct exerted a dominant effect over the other. After transfection with equal amounts of cDNA, we found cells where both WT and mutant proteins displayed the phenotype of the mutant construct, whereas in other cases, junctional plaques could be easily discerned (although an outline of the cell, likely resulting from the presence of the FLAG-tagged mutant protein, could still be observed [see red signal in Figure 5D ]). These results can be explained if we assume that the probability of proper targeting and integration of a connexon into a plaque decreases as a function of the number of mutant subunits contained. For cotransfection, we used equal amounts of cDNA; however, it is very likely that each cell was transfected with variable amounts of each construct and, thus, expressed variable amounts of each protein. We speculate that a majority (though of unknown stoichiometry) of WT connexin subunits are required in a connexon for proper formation of functional gap junctions. Thus, if a cell captures an abundance of Q58L cDNA, most oligomers will contain an excess of mutant subunits, and gap junction formation will fail. If, on the other hand, that cell captures and expresses more of the WT cDNA, the distribution of the subunits within the oligomer will contain a majority of WT connexins, and the connexon will be properly integrated into a channel. This hypothesis will require further testing, although data presented in Figure 6 support the concept that success or failure of functional channel formation may relate to relative abundance of each protein (WT or mutant). If our hypothesis is correct, it suggests that the distribution of functional gap junctions in the His-Purkinje network of affected individuals could vary significantly among cells, depending on the extent of expression of each allele in each cell. The resulting phenotype may be that of a Purkinje network where gap junction-mediated coupling could be heterogeneous, setting the stage for local conduction block, microreentry, and ventricular arrhythmias at the Purkinje network or at the Purkinje-muscle junction. 1, 2 Overall, we show that both proband and sister have a genotype that (1) is absent in hundreds of control subjects and in the unaffected parent (the father), (2) disrupts an important functional domain of the protein, and (3) disrupts the formation of gap junction channels. The data therefore support the notion of an association between the Cx40 mutation and the clinical phenotype and emphasize the importance of future studies to assess the possible involvement of Cx40 mutations as causative of the disease.
